Cargando…

Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice

AIM: Gelsemine, an alkaloid from the Chinese herb Gelsemium elegans (Gardn & Champ) Benth., is effective in mitigating chronic pain in rats. In the present study we investigated whether the alkaloid improved sleep disturbance, the most common comorbid symptoms of chronic pain, in a mouse model o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-er, Li, Ya-dong, Luo, Yan-jia, Wang, Tian-xiao, Wang, Hui-jing, Chen, Shuo-nan, Qu, Wei-min, Huang, Zhi-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635333/
https://www.ncbi.nlm.nih.gov/pubmed/26388157
http://dx.doi.org/10.1038/aps.2015.86
_version_ 1782399486672240640
author Wu, Yu-er
Li, Ya-dong
Luo, Yan-jia
Wang, Tian-xiao
Wang, Hui-jing
Chen, Shuo-nan
Qu, Wei-min
Huang, Zhi-li
author_facet Wu, Yu-er
Li, Ya-dong
Luo, Yan-jia
Wang, Tian-xiao
Wang, Hui-jing
Chen, Shuo-nan
Qu, Wei-min
Huang, Zhi-li
author_sort Wu, Yu-er
collection PubMed
description AIM: Gelsemine, an alkaloid from the Chinese herb Gelsemium elegans (Gardn & Champ) Benth., is effective in mitigating chronic pain in rats. In the present study we investigated whether the alkaloid improved sleep disturbance, the most common comorbid symptoms of chronic pain, in a mouse model of neuropathic pain. METHODS: Mice were subjected to partial sciatic nerve ligation (PSNL). After the mice were injected with gelsemine or pregabalin (the positive control) intraperitoneally, mechanical allodynia and thermal hyperalgesia were assessed, and electroencephalogram (EEG)/electromyogram (EMG) recording was performed. Motor performance of the mice was assessed using rota-rod test. c-Fos expression in the brain was analyzed with immunohistochemical staining. RESULTS: In PSNL mice, gelsemine (2 and 4 mg/kg) increased the mechanical threshold for 4 h and prolonged the thermal latencies for 3 h. Furthermore, gelsemine (4 mg/kg, administered at 6:30 AM) increased non-rapid eye movement (non-REM, NREM) sleep, decreased wakefulness, but did not affect REM sleep during the first 3 h in PSNL mice. Sleep architecture analysis showed that gelsemine decreased the mean duration of wakefulness and increased the total number of episodes of NREM sleep during the first 3 h after the dosing. Gelsemine (4 mg/kg) did not impair motor coordination in PSNL mice. Immunohistochemical study showed that PSNL increased c-Fos expression in the neurons of the anterior cingulate cortex, and gelsemine (4 mg/kg) decreased c-Fos expression by 58%. Gelsemine (4 mg/kg, administered at either 6:30 AM or 8:30 PM) did not produce hypnotic effect in normal mice. Pregabalin produced similar antinociceptive and hypnotic effects, but impaired motor coordination in PSNL mice. CONCLUSION: Gelsemine is an effective agent for treatment of both neuropathic pain and sleep disturbance in PSNL mice; anterior cingulate cortex might play a role in the hypnotic effects of gelsemine.
format Online
Article
Text
id pubmed-4635333
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46353332015-11-25 Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice Wu, Yu-er Li, Ya-dong Luo, Yan-jia Wang, Tian-xiao Wang, Hui-jing Chen, Shuo-nan Qu, Wei-min Huang, Zhi-li Acta Pharmacol Sin Original Article AIM: Gelsemine, an alkaloid from the Chinese herb Gelsemium elegans (Gardn & Champ) Benth., is effective in mitigating chronic pain in rats. In the present study we investigated whether the alkaloid improved sleep disturbance, the most common comorbid symptoms of chronic pain, in a mouse model of neuropathic pain. METHODS: Mice were subjected to partial sciatic nerve ligation (PSNL). After the mice were injected with gelsemine or pregabalin (the positive control) intraperitoneally, mechanical allodynia and thermal hyperalgesia were assessed, and electroencephalogram (EEG)/electromyogram (EMG) recording was performed. Motor performance of the mice was assessed using rota-rod test. c-Fos expression in the brain was analyzed with immunohistochemical staining. RESULTS: In PSNL mice, gelsemine (2 and 4 mg/kg) increased the mechanical threshold for 4 h and prolonged the thermal latencies for 3 h. Furthermore, gelsemine (4 mg/kg, administered at 6:30 AM) increased non-rapid eye movement (non-REM, NREM) sleep, decreased wakefulness, but did not affect REM sleep during the first 3 h in PSNL mice. Sleep architecture analysis showed that gelsemine decreased the mean duration of wakefulness and increased the total number of episodes of NREM sleep during the first 3 h after the dosing. Gelsemine (4 mg/kg) did not impair motor coordination in PSNL mice. Immunohistochemical study showed that PSNL increased c-Fos expression in the neurons of the anterior cingulate cortex, and gelsemine (4 mg/kg) decreased c-Fos expression by 58%. Gelsemine (4 mg/kg, administered at either 6:30 AM or 8:30 PM) did not produce hypnotic effect in normal mice. Pregabalin produced similar antinociceptive and hypnotic effects, but impaired motor coordination in PSNL mice. CONCLUSION: Gelsemine is an effective agent for treatment of both neuropathic pain and sleep disturbance in PSNL mice; anterior cingulate cortex might play a role in the hypnotic effects of gelsemine. Nature Publishing Group 2015-11 2015-09-21 /pmc/articles/PMC4635333/ /pubmed/26388157 http://dx.doi.org/10.1038/aps.2015.86 Text en Copyright © 2015 CPS and SIMM http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Wu, Yu-er
Li, Ya-dong
Luo, Yan-jia
Wang, Tian-xiao
Wang, Hui-jing
Chen, Shuo-nan
Qu, Wei-min
Huang, Zhi-li
Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice
title Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice
title_full Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice
title_fullStr Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice
title_full_unstemmed Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice
title_short Gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice
title_sort gelsemine alleviates both neuropathic pain and sleep disturbance in partial sciatic nerve ligation mice
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635333/
https://www.ncbi.nlm.nih.gov/pubmed/26388157
http://dx.doi.org/10.1038/aps.2015.86
work_keys_str_mv AT wuyuer gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice
AT liyadong gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice
AT luoyanjia gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice
AT wangtianxiao gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice
AT wanghuijing gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice
AT chenshuonan gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice
AT quweimin gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice
AT huangzhili gelseminealleviatesbothneuropathicpainandsleepdisturbanceinpartialsciaticnerveligationmice